• Common shares of LevelJump (JUMP) are now eligible for electronic clearing and settlement through the DTC
  • DTC eligibility simplifies the process of trading and transferring the company’s common shares between brokerages in the United States
  • LevelJump’s common shares will continue to trade under the ticker symbol JMPHF on the OTCQB
  • LevelJump Healthcare is a national medical diagnostic imaging company providing radiology support to hospitals, emergency rooms and private clinics
  • LevelJump Healthcare Corp. (JUMP) is up 5.56 per cent, trading at C$0.19 per share at 1:30 pm ET

Common shares of LevelJump (JUMP) are now eligible for electronic clearing and settlement through the DTC. 

DTC is a subsidiary of the Depository Trust & Clearing Corp. (DTCC) that manages the electronic clearing and settlement of publicly-traded companies in the United States.

LevelJump’s common shares will continue to trade under the ticker symbol JMPHF on the OTCQB.

Through an electronic method of clearing securities, DTC eligibility simplifies the process of trading and transferring the company’s common shares between brokerages in the United States.

Mitch Geisler, CEO commented on the benefits of DTC eligibility.

“With DTC eligibility, our shares will be more accessible to a broader range of investors in the U.S. This should allow LevelJump to increase its global shareholder base and increase the liquidity of our common shares to the benefit of all investors.” 

LevelJump Healthcare is building a national medical diagnostic imaging company and brand, primarily by providing teleradiology (remote radiology) services to its client hospitals and imaging centers.

LevelJump Healthcare Corp. (JUMP) is up 5.56 per cent, trading at C$0.19 per share at 1:30 pm ET.

More From The Market Online

Reliq Health expands contract with U.S. health group

Reliq Health Technologies (TSXV:RHT) reveals it has expanded an existing contract with a large U.S. health group.

Telo Genomics and Emery Pharma collaborate

Telo Genomics (TSXV:TELO) collaborates with Emery Pharma to enhance cellular and molecular bioanalytical solutions for clinical research.

UniDoc brings AI to ER patients

UniDoc (CSE:UDOC) expands its AI partnership with DocBox, further integrating predictive analytics into emergency room operations.